Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Management to Present at March Conferences

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 25, 2004--Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Management will present at two conferences in March 2004.

On Thursday, March 4th, at 10:15 a.m. EST, Chairman, President and Chief Executive Officer James C. Foster will present at Lehman Brothers' Seventh Annual Global Healthcare Conference in Miami, Florida.

On Wednesday, March 10th, at 8:00 a.m. and 9:00 a.m. EST, James C. Foster and Senior Vice President and Chief Financial Officer Thomas F. Ackerman will present at the SG Cowen 24th Annual Healthcare Conference in Boston, Massachusetts.

A live webcast of each presentation will be available through links that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay for each conference will be accessible through the same website approximately three hours after the presentations and will remain available until March 17, 2004.


    CONTACT: Charles River Laboratories International, Inc.
             Susan E. Hardy, 978-658-6000 ext.1616

    SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)